Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALGeneric

URISPAS

FLAVOXATE HYDROCHLORIDE

Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Discontinued
  • Approval overview URISPAS is listed in Drugs@FDA under application 016769 (NDA).
  • Review priority: STANDARD Marketing status: Discontinued Active ingredient FLAVOXATE HYDROCHLORIDE Form and strength TABLET;ORAL - 100MG Sponsor ORTHO MCNEIL JANSSEN Submission history Latest submission status date: 2001-01-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview URISPAS is listed in Drugs@FDA under application 016769 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FLAVOXATE HYDROCHLORIDE Form and strength TABLET;ORAL - 100MG Sponsor ORTHO MCNEIL JANSSEN Submission history Latest submission status date: 2001-01-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.